Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ARDELYX, INC.ARDX · Entity 4972 | See Remarks | November 21, 2025 | November 25, 2025 |
| Sagimet Biosciences Inc.SGMT · Entity 5273 | Director | June 12, 2026 | June 15, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ARDELYX, INC.
Report date November 21, 2025 · Filed November 25, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 299,895 |
Reported balance
After 2025-11-21 transaction · row 1
1 source rowRow 1 · 2025-11-21 · Sale · Disposed 5,995 · Balance 299,895 F1: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.
Sagimet Biosciences Inc.
Report date June 12, 2026 · Filed June 15, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.48 · Expires 2036-06-11 | Direct | 39,567 |
Reported balance
After 2026-06-12 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-12 · Grant · Acquired 39,567 · Balance 39,567 F1: The shares underlying this option shall vest and become exercisable over twelve (12) equal monthly installments following June 12, 2026, subject to the Reporting Person's continued service on each such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares underlying this option shall vest and become exercisable over twelve (12) equal monthly installments following June 12, 2026, subject to the Reporting Person's continued service on each such vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 19, 2017 Filed Jan 24, 2017 01:51 UTC | ARDELYX, INC. ARDX · Entity 4972 | GrantCommon Stock | 17,985 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-002602 · doc1.xml · nonDerivative · entry 1 GRAMMER ELIZABETH A · CIK 0001213041 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,985 F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof. Read SEC document |
| September 23, 2016 Filed Sep 27, 2016 00:31 UTC | ARDELYX, INC. ARDX · Entity 4972 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $3.42 | $0.00 |
DisclosureSEC source: 0001140361-16-080765 · doc1.xml · derivative · entry 8 GRAMMER ELIZABETH A · CIK 0001213041 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 2,500 shares Expires 2022-11-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 19, 2016. F2 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| September 23, 2016 Filed Sep 27, 2016 00:31 UTC | ARDELYX, INC. ARDX · Entity 4972 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,060 | $0.00 Strike: $1.08 | $0.00 |
DisclosureSEC source: 0001140361-16-080765 · doc1.xml · derivative · entry 7 GRAMMER ELIZABETH A · CIK 0001213041 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,060 shares Expires 2021-04-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 19, 2016. F2 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| September 23, 2016 Filed Sep 27, 2016 00:31 UTC | ARDELYX, INC. ARDX · Entity 4972 | SaleCommon Stock | 3,560 | $12.00 | $42,720.00 |
DisclosureSEC source: 0001140361-16-080765 · doc1.xml · nonDerivative · entry 5 GRAMMER ELIZABETH A · CIK 0001213041 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 19, 2016. Read SEC document |
| September 23, 2016 Filed Sep 27, 2016 00:31 UTC | ARDELYX, INC. ARDX · Entity 4972 | Exercise / conversionCommon Stock | 2,500 | $3.42 | $8,550.00 |
DisclosureSEC source: 0001140361-16-080765 · doc1.xml · nonDerivative · entry 4 GRAMMER ELIZABETH A · CIK 0001213041 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,560 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 19, 2016. Read SEC document |
| September 23, 2016 Filed Sep 27, 2016 00:31 UTC | ARDELYX, INC. ARDX · Entity 4972 | Exercise / conversionCommon Stock | 1,060 | $1.08 | $1,144.80 |
DisclosureSEC source: 0001140361-16-080765 · doc1.xml · nonDerivative · entry 3 GRAMMER ELIZABETH A · CIK 0001213041 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,060 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 19, 2016. Read SEC document |
| September 22, 2016 Filed Sep 27, 2016 00:31 UTC | ARDELYX, INC. ARDX · Entity 4972 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,440 | $0.00 Strike: $1.08 | $0.00 |
DisclosureSEC source: 0001140361-16-080765 · doc1.xml · derivative · entry 6 GRAMMER ELIZABETH A · CIK 0001213041 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,060 Underlying: Common Stock · 1,440 shares Expires 2021-04-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 19, 2016. F2 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| September 22, 2016 Filed Sep 27, 2016 00:31 UTC | ARDELYX, INC. ARDX · Entity 4972 | SaleCommon Stock | 1,440 | $12.00 | $17,280.00 |
DisclosureSEC source: 0001140361-16-080765 · doc1.xml · nonDerivative · entry 2 GRAMMER ELIZABETH A · CIK 0001213041 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 19, 2016. Read SEC document |
| September 22, 2016 Filed Sep 27, 2016 00:31 UTC | ARDELYX, INC. ARDX · Entity 4972 | Exercise / conversionCommon Stock | 1,440 | $1.08 | $1,555.20 |
DisclosureSEC source: 0001140361-16-080765 · doc1.xml · nonDerivative · entry 1 GRAMMER ELIZABETH A · CIK 0001213041 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,440 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 19, 2016. Read SEC document |
| September 19, 2016 Filed Sep 21, 2016 23:52 UTC | ARDELYX, INC. ARDX · Entity 4972 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $1.08 | $0.00 |
DisclosureSEC source: 0001140361-16-080481 · doc1.xml · derivative · entry 4 GRAMMER ELIZABETH A · CIK 0001213041 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 2,500 shares Expires 2021-04-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 19, 2016. F4 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| September 19, 2016 Filed Sep 21, 2016 23:52 UTC | ARDELYX, INC. ARDX · Entity 4972 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $1.08 | $0.00 |
DisclosureSEC source: 0001140361-16-080481 · doc1.xml · derivative · entry 3 GRAMMER ELIZABETH A · CIK 0001213041 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,500 shares Expires 2020-10-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 19, 2016. F4 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| September 19, 2016 Filed Sep 21, 2016 23:52 UTC | ARDELYX, INC. ARDX · Entity 4972 | SaleCommon Stock | 6,859 | $11.21 | $76,880.47 |
DisclosureSEC source: 0001140361-16-080481 · doc1.xml · nonDerivative · entry 2 GRAMMER ELIZABETH A · CIK 0001213041 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 19, 2016. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.04 to $11.26, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| September 19, 2016 Filed Sep 21, 2016 23:52 UTC | ARDELYX, INC. ARDX · Entity 4972 | Exercise / conversionCommon Stock | 5,000 | $1.08 | $5,400.00 |
DisclosureSEC source: 0001140361-16-080481 · doc1.xml · nonDerivative · entry 1 GRAMMER ELIZABETH A · CIK 0001213041 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,859 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 19, 2016. F2 · balance_after: Includes an aggregate of 1,859 shares acquired under the Issuer's Employee Stock Purchase Plan on February 29, 2016. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.